[1]
|
Buono, J.L., Carson, R.T. and Flores, N.M. (2017) Health-Related Quality of Life, Work Productivity, and Indirect Costs among Patients with Irritable Bowel Syndrome with Diarrhea. Health and Quality of Life Outcomes, 15, Article No. 35. https://doi.org/10.1186/s12955-017-0611-2
|
[2]
|
Lacy, B.E. and Patel, N.K. (2017) Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. Journal of Clinical Medicine, 6, Article 99. https://doi.org/10.3390/jcm6110099
|
[3]
|
Sperber, A.D., Bangdiwala, S.I., Drossman, D.A., et al. (2021) World-wide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gas-troenterology, 160, 99-114.E3.
|
[4]
|
Vasant, D.H., Paine, P.A., Black, C.J., et al. (2021) British Society of Gastroenter-ology Guidelines on the Management of Irritable Bowel Syndrome. Gut, 70, 1214-1240. https://doi.org/10.1136/gutjnl-2021-324598
|
[5]
|
杨芳, 严晶, 刘丽娜, 等. 肠易激综合征病因及发病机制研究的新进展[J]. 河北医科大学学报, 2020, 41(8): 987-992.
|
[6]
|
Tian, S., Zhang, H., Chen, S., et al. (2023) Global Re-search Progress of Visceral Hypersensitivity and Irritable Bowel Syndrome: Bibliometrics and Visualized Analysis. Frontiers in Pharmacology, 14, Article 1175057.
https://doi.org/10.3389/fphar.2023.1175057
|
[7]
|
Mayer, E.A. (2011) Gut Feelings: The Emerging Biology of Gut-Brain Communication. Nature Reviews Neuroscience, 12, 453-466. https://doi.org/10.1038/nrn3071
|
[8]
|
Mawdsley, J.E. and Rampton, D.S. (2005) Psychological Stress in IBD: New Insights into Pathogenic and Therapeutic Implications. Gut, 54, 1481-1491. https://doi.org/10.1136/gut.2005.064261
|
[9]
|
Koloski, N.A., Jones, M., Kalantar, J., et al. (2012) The Brain—Gut Pathway in Functional Gastrointestinal Disorders Is Bidirectional: A 12-Year Prospective Population-Based Study. Gut, 61, 1284-1290.
https://doi.org/10.1136/gutjnl-2011-300474
|
[10]
|
Koloski, N.A., Jones, M. and Talley, N.J. (2016) Evidence That Independent Gut-to-Brain and Brain-to-Gut Pathways Operate in the Irritable Bowel Syndrome and Functional Dyspep-sia: A 1-Year Population-Based Prospective Study. Alimentary Pharmacology & Therapeutics, 44, 592-600. https://doi.org/10.1111/apt.13738
|
[11]
|
Sender, R., Fuchs, S. and Milo, R. (2016) Are We Really Vastly Outnum-bered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, 164, 337-340. https://doi.org/10.1016/j.cell.2016.01.013
|
[12]
|
De Vos, W.M., Tilg, H., Van Hul, M. and Cani, P.D. (2022) Gut Microbiome and Health: Mechanistic Insights. Gut, 71, 1020-1032. https://doi.org/10.1136/gutjnl-2021-326789
|
[13]
|
Leonardi, I., Gao, I.H., Lin, W.Y., et al. (2022) Mucosal Fungi Promote Gut Barrier Function and Social Behavior via Type 17 Immunity. Cell, 185, 831-846.E14. https://doi.org/10.1016/j.cell.2022.01.017
|
[14]
|
Hookway, C., Buckner, S., Crosland, P., et al. (2015) Irritable Bowel Syndrome in Adults in Primary Care: Summary of Updated NICE Guidance. BMJ, 350, h701. https://doi.org/10.1136/bmj.h701
|
[15]
|
Li, C.Y. and Li, S.C. (2015) Treatment of Irritable Bowel Syndrome in Chi-na: A Review. World Journal of Gastroenterology, 21, 2315-2322. https://doi.org/10.3748/wjg.v21.i8.2315
|
[16]
|
Chang, L., Lembo, A. and Sultan, S. (2014) American Gastroentero-logical Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome. Gas-troenterology, 147, 1149-1172.E2.
https://doi.org/10.1053/j.gastro.2014.09.002
|
[17]
|
Nam, Y., Min, Y.S. and Sohn, U.D. (2018) Recent Advances in Pharmacological Research on the Management of Irritable Bowel Syndrome. Archives of Pharmacal Research, 41, 955-966. https://doi.org/10.1007/s12272-018-1068-5
|
[18]
|
Naliboff, B.D., Frese, M.P. and Rapgay, L. (2008) Mind/Body Psychological Treatments for Irritable Bowel Syndrome. Evidence-Based Complementary and Alternative Medicine, 5, Article ID: 919413.
https://doi.org/10.1093/ecam/nem046
|
[19]
|
Jeffery, I.B., Quigley, E.M., Ohman, L., et al. (2012) The Microbiota Link to Irritable Bowel Syndrome: An Emerging Story. Gut Microbes, 3, 572-576. https://doi.org/10.4161/gmic.21772
|
[20]
|
Parkes, G.C., Rayment, N.B., Hudspith, B.N., et al. (2012) Distinct Mi-crobial Populations Exist in the Mucosa-Associated Microbiota of Sub-Groups of Irritable Bowel Syndrome. Neurogas-troenterology & Motility, 24, 31-39.
https://doi.org/10.1111/j.1365-2982.2011.01803.x
|
[21]
|
Jeffery, I.B., O’toole, P.W., Öhman, L., et al. (2012) An Irritable Bowel Syndrome Subtype Defined by Species-Specific Alterations in Faecal Microbiota. Gut, 61, 997-1006. https://doi.org/10.1136/gutjnl-2011-301501
|
[22]
|
Labus, J.S., Hollister, E.B., Jacobs, J., et al. (2017) Differences in Gut Microbial Composition Correlate with Regional Brain Volumes in Irritable Bowel Syndrome. Microbiome, 5, Article No. 49.
https://doi.org/10.1186/s40168-017-0260-z
|
[23]
|
Tap, J., Derrien, M., Tornblom, H., et al. (2017) Identification of an Intestinal Microbiota Signature Associated with Severity of Irritable Bowel Syndrome. Gastroenterology, 152, 111-123.E8.
https://doi.org/10.1053/j.gastro.2016.09.049
|
[24]
|
Hugerth, L.W., Andreasson, A., Talley, N.J., et al. (2020) No Distinct Microbiome Signature of Irritable Bowel Syndrome Found in a Swedish Random Population. Gut, 69, 1076-1084. https://doi.org/10.1136/gutjnl-2019-318717
|
[25]
|
Jeffery, I.B., O’herlihy, E., Shanahan, F. and O’Toole, P.W. (2020) Microbiome Alterations in IBS. Gut, 69, 2263-2264.
https://doi.org/10.1136/gutjnl-2020-320919
|
[26]
|
Kennedy, P.J., Cryan, J.F., Dinan, T.G. and Clarke, G. (2014) Ir-ritable Bowel Syndrome: A Microbiome-Gut-Brain Axis Disorder? World Journal of Gastroenterology, 20, 14105-14125. https://doi.org/10.3748/wjg.v20.i39.14105
|
[27]
|
Crouzet, L., Gaultier, E., Del’homme, C., et al. (2013) The Hypersensitivity to Colonic Distension of IBS Patients Can Be Transferred to Rats through Their Fecal Mi-crobiota. Neurogastroenterology & Motility, 25, e272-e282.
https://doi.org/10.1111/nmo.12103
|
[28]
|
De Palma, G., Lynch, M.D.J., Lu, J., et al. (2017) Transplantation of Fecal Microbiota from Patients with Irritable Bowel Syndrome Alters Gut Function and Behavior in Recipient Mice. Science Translational Medicine, 9, eaaf6397.
|
[29]
|
Johnsen, P.H., Hilpusch, F., Cavanagh, J.P., et al. (2018) Faecal Microbiota Transplantation versus Placebo for Moderate-to-Severe Irritable Bowel Syndrome: A Double-Blind, Randomised, Place-bo-Controlled, Parallel-Group, Single-Centre Trial. The Lancet Gastroenterology and Hepatology, 3, 17-24.
https://doi.org/10.1016/S2468-1253(17)30338-2
|
[30]
|
El-Salhy, M., Hatlebakk, J.G., Gilja, O.H., et al. (2020) Ef-ficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-Blind, Placebo-Controlled Study. Gut, 69, 859-867.
https://doi.org/10.1136/gutjnl-2019-319630
|
[31]
|
Goll, R., Johnsen, P.H., Hjerde, E., et al. (2020) Effects of Fecal Microbiota Transplantation in Subjects with Irritable Bowel Syndrome Are Mirrored by Changes in Gut Microbiome. Gut Microbes, 12, Article ID: 1794263.
https://doi.org/10.1080/19490976.2020.1794263
|
[32]
|
El-Salhy, M., Winkel, R., Casen, C., et al. (2022) Efficacy of Fecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome at 3 Years after Transplantation. Gastroen-terology, 163, 982-994.E14.
https://doi.org/10.1053/j.gastro.2022.06.020
|
[33]
|
Halkjaer, S.I., Christensen, A.H., Lo, B.Z.S., et al. (2018) Faecal Microbiota Transplantation Alters Gut Microbiota in Patients with Irritable Bowel Syndrome: Results from a Randomised, Double-Blind Placebo-Controlled Study. Gut, 67, 2107-2115. https://doi.org/10.1136/gutjnl-2018-316434
|
[34]
|
Zhou, S.Y., Gillilland III., M., Wu, X., et al. (2018) FODMAP Diet Modulates Visceral Nociception by Lipopolysaccharide-Mediated Intestinal Inflammation and Barrier Dysfunction. Journal of Clinical Investigation, 128, 267-280.
https://doi.org/10.1172/JCI92390
|
[35]
|
Vervier, K., Moss, S., Kumar, N., et al. (2022) Two Microbiota Subtypes Identified in Irritable Bowel Syndrome with Distinct Responses to the Low FODMAP Diet. Gut, 71, 1821-1830. https://doi.org/10.1136/gutjnl-2021-325177
|
[36]
|
Mcintosh, K., Reed, D.E., Schneider, T., et al. (2017) FODMAPs Alter Symptoms and the Metabolome of Patients with IBS: A Randomised Controlled Trial. Gut, 66, 1241-1251. https://doi.org/10.1136/gutjnl-2015-311339
|
[37]
|
Staudacher, H.M., Lomer, M.C.E., Farquharson, F.M., et al. (2017) A Diet Low in FODMAPs Reduces Symptoms in Patients with Irritable Bowel Syndrome and a Probiotic Re-stores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology, 153, 936-947. https://doi.org/10.1053/j.gastro.2017.06.010
|
[38]
|
Ispiryan, L., Zannini, E. and Arendt, E.K. (2022) FODMAP Modulation as a Dietary Therapy for IBS: Scientific and Market Perspective. Comprehensive Reviews in Food Science and Food Safety, 21, 1491-1516.
https://doi.org/10.1111/1541-4337.12903
|